GlassScriptPhysician profile
Jack Guillory
NPI 1396444766
$3,452.95
in general payments reported to CMS, 2019-2025
6 companies · $2,787 in 2025
The $2,787 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $554 · 2024: $112 · 2025: $2,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,200 · Food and Beverage: $1,059 · Travel and Lodging: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,200.00 |
| Food and Beverage | $1,059.02 |
| Travel and Lodging | $193.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $2,707.83 | 2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $314.07 | 2023 | Xiaflex |
| Boston Scientific Corporation | $147.91 | 2023-2025 | Ams 700 |
| Sumitomo Pharma America, INC. | $140.23 | 2023-2025 | Gemtesa |
| Axonics, INC. | $92.91 | 2023-2024 | Axonics |
| Antares Pharma, INC. | $50.00 | 2023 | Tlando, Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Guillory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.